ONIDA, FRANCESCO
ONIDA, FRANCESCO
Dipartimento di Oncologia ed Emato-Oncologia
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia
2026 L. Lanino, A.M. Hunter, N. Gagelmann, M. Robin, D. Dall'Olio, A. Flamigni, C. Sala, C. Gurnari, Y. Wang, L. Pleyer, B. Xicoy, G. Montalban-Bravo, L. Shih, A. Alsugair, S. Fathima, C. Gregorio, C. Rollo, L. Palomo, A.S. Platzbecker, G. Asti, R. Itzykson, D.A. Sallman, P. Fariselli, W. Kern, G. Garcia-Manero, U. Platzbecker, F. Solé, M. Diez-Campelo, J. Maciejewski, R. Bejar, F. Thol, N. Kroger, M. Savona, P. Fenaux, G. Sanz, S. Kordasti, V. Santini, M. Fontenay, A.M. Zeidan, R.S. Komrokji, T. Haferlach, U. Germing, G. Castellani, S. D'Amico, M. Patnaik, F. Ieva, E. Solary, A. Tefferi, E. Padron, M.G. Della Porta, N. Null, T. Haque, O. Abdel-Wahab, K. Geissler, A. Bataller, A. Bazinet, M. Meggendorfer, M. Quintavalla, A. Bruseghini, E. Sauta, L. Carota, T. Sanavia, L. Dall'Olio, E. Travaglino, L. Zamora, D. Quintela, A. Jerez, E. Cornejo, P. Garcia Martin, M. Diaz-Beya, A. Avendano Pita, V. Roldan, D.V. Fiallo Suárez, E. Cerezo Velasco, M. Calabuig, E. Such, C. Castilla-Llorente, C.E. Bulabois, L. Souchet, H. Awada, M. Bernardi, P. Chiusolo, A. Curti, L. Giaccone, C. Finelli, I. Casetti, F. Onida, L.M. Borin, M. Yung Follo, A. Consagra, F. Passamonti, E. Diral, V. Vucinic, G.M. Bergonzi, M.T. Voso, H. Hou, W. Chou, C. Yao, C. Lin, H. Tien, A. Campagna, M. Ubezio, A. Russo, G. Todisco, G. Maggioni, C.A. Tentori, A. Buizza, I. Ferrari, M. Di Matteo, A. Crespi, G. Figini, C. Delponte, F. Pesce, M. Zampini, E. Riva, M. Delleani, E. Iascone, L. Crisafulli, F. Ficara, D. Ventura, N. Pinocchio, M. Brindisi, A. Santoro, A. Kiwan, J. Vanoudenhove, N.H. Al Ali, T.A. Graubert, S. Thota, E. Griffiths
Clinical-genomic profiling of MDS to inform allo-HCT: recommendations from an international panel on behalf of the EBMT
2025 C. Gurnari, M. Robin, L. Adès, M. Aljurf, A. Almeida, F.B. Duarte, E. Bernard, C. Cutler, M.G. Della Porta, T. De Witte, A. Dezern, J. Drozd-Sokolowska, E. Duncavage, P. Fenaux, N. Gagelmann, G. Garcia-Manero, C. Haferlach, T. Haferlach, R. Hasserjian, E. Hellström-Lindberg, M. Jacoby, A. Kulasekararaj, R.C. Lindsley, J.P. Maciejewski, H. Makishima, L. Malcovati, M. Mittelman, A.E. Myhre, S. Ogawa, F. Onida, E. Papaemmanuil, J. Passweg, U. Platzbecker, L. Pleyer, K. Raj, V. Santini, A. Sureda, M. Tobiasson, M.T. Voso, I. Yakoub-Agha, A. Zeidan, M. Walter, N. Kröger, D.P. Mclornan, M. Cazzola
BLAST: A Globally Applicable and Molecularly Versatile Survival Model for Chronic Myelomonocytic Leukemia
2025 A. Tefferi, S. Fathima, M. Abdelmagid, A. Alsugair, F. Aperna, M. Rezasoltani, M. Yousuf, A. Natu, C.M. Csizmar, M. Gurney, T.L. Lasho, C.M. Finke, R. Kanagal-Shamanna, D. Hammond, K.S. Chien, A. Bazinet, C.D. Dinardo, T.M. Kadia, A.A. Mangaonkar, N.G. Daver, A.D. Pardanani, G. Borthakur, C.J. Zepeda-Mendoza, K.K. Reichard, R. He, S. Loghavi, F. Passamonti, F. Ravandi, K. Sasaki, D. Larson, G. Garcia-Manero, F. Onida, N. Gangat, G. Montalban-Bravo, M.M. Patnaik
Clinical Impact of Graft Cryopreservation on Allogeneic Stem Cell Transplantation: An Italian, Registry‐Based Study on Behalf of the “Gruppo Italiano Per Il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare” (GITMO)
2025 I. Defrancesco, V.V. Ferretti, P. Chiusolo, D. Russo, C. Nozzoli, A. Olivieri, M. Gambella, I.M. Cavattoni, S. Bramanti, S. Santarone, R. Fanin, R. Cairoli, S. Piemontese, M. Parma, F. Onida, A. Busca, L. Castagna, A. Cuoghi, D. Pastore, N. Mordini, F. Benedetti, C. Skert, C. Borghero, A.P. Iori, F. Fagioli, V. Pavone, C. Selleri, S. Cesaro, M. Musso, M. Ladetto, D. Vallisa, P. Carluccio, A. Picardi, M. Tozzi, A. Biffi, G. Milone, M. Faraci, A. Prete, L. Prezioso, A.M. Risitano, F.P. Tambaro, V. Tintori, P. Galieni, F. Pane, C. Zerbi, A. Bianchessi, G. Losi, F. Romano, A. Taurino, E. Oldani, N. Polverelli, F. Bonifazi, M. Martino
Urgent need: evidence-based use of donor lymphocyte infusions – Authors' reply
2025 S. Pagliuca, C. Schmid, N. Santoro, F. Simonetta, G. Battipaglia, T. Guillaume, R. Greco, F. Onida, I. Sánchez-Ortega, I. Yakoub-Agha, F. Malard, J. Kuball, M.D. Hazenberg, A. Ruggeri
Allogeneic haematopoietic cell transplantation in peripheral T-cell lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
2025 G. Damaj, A. Bazarbachi, P. Berning, A. Cottereau, C.P. Fox, C. Kyriakou, K. Cwynarski, P. Zinzani, O. Tournilhac, W. Jurczak, I.E. Karsten, F. Wang, A. Marcais, A. Tanase, S. Nguyen-Quoc, Y. Serroukh, M. Aljurf, D. Beauvais, G. Wulf, A. Sureda, P. Corradini, O. Hermine, M. Hamadani, F. Onida, A.L. Ruggeri, I. Sanchez-Ortega, I. Yakoub-Agha, P. Dreger, N. Schmitz
Allogeneic hematopoietic cell transplant in cutaneous T-cell lymphomas: recommendations from the EBMT PH&G Committee
2025 G. Damaj, A. De Masson, P. Dreger, A. Bazarbachi, P. Berning, R.F. Duarte, C.P. Fox, E. Guenova, O. Hermine, C. Kyriakou, A. Tanase, O. Tournilhac, W. Jurczak, I.E. Karsten, S.N. Quoc, Y. Serroukh, F. Stella, G. Wulf, A. Sureda, E. Papadavid, P.L. Ortiz-Romero, A. Ruggeri, I. Sanchez-Ortega, J.J. Scarisbrick, I. Yakoub-Agha, F. Onida, N. Schmitz
Posttransplant cyclophosphamide as GVHD prophylaxis in patients receiving mismatched unrelated HCT: the PHYLOS trial
2025 A.M. Raiola, B. Bruno, A.M. Risitano, F. Mosna, I.M. Cavattoni, F. Onida, G. Saporiti, F. Patriarca, M.L. Battista, V. Pavone, A. Mele, P. Chiusolo, S. Sica, B. Loteta, C. Di Grazia, A.M. Carella, D. Salvatore, E. Morello, A. Leoni, L. Giaccone, P. Bernasconi, E. Terruzzi, N. Mordini, C. Borghero, F. Zallio, M. Luppi, A. Grassi, A. Olivieri, E. Piras, N. Sacchi, G. Ciccone, A. Castiglione, E. Degrandi, E. Angelucci, M. Martino, F. Bonifazi
The Changing Impact of Human Cytomegalovirus Serology and Infection on Patient Outcome After Allogeneic Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey in the Era of Letermovir Prophylaxis
2025 C. Girmenia, P. Chiusolo, G. Marsili, A. Piciocchi, M.C. Micò, R. Greco, G. Porto, F. Galaverna, F. Bonifazi, I. Cutini, M. Malagola, S. Bramanti, A. Busca, A.M. Carella, A. Carotti, A.P. Iori, F. Onida, R. Bono, E. Terruzzi, A. Vacca, A. Rinaldi, I.M. Cavattoni, A. Picardi, M. Faraci, T. Lazzarotto, F. Baldanti, P. Clerici, L. Castagna, M. Martino, F. Ciceri
Less frequent complications following CAR T-cell therapies: hemophagocytic lymphohistiocytosis, graft-versus-host disease, thrombotic microangiopathy, coagulation disorders and secondary malignancies: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee
2025 G. Ortí, G. Dachy, C.E. Graham, Z. Peric, A. Alarcon, F. Del Bufalo, M. Doglio, J. Henter, C. Roddie, O. Stewart, W.C.J. Van De Donk, R. Velasco, M. Aljurf, A. Ruggeri, F. Onida, I. Sánchez-Ortega, I. Yakoub-Agha, O. Penack
Allogeneic haematopoietic cell transplant in cutaneous T-cell lymphomas: Recommendations from the EBMT PH&G Committee
2025 G. Damaj, A. De Masson, P. Dreger, A. Bazarbachi, P. Berning, R.F. Duarte, C.P. Fox, E. Guenova, O. Hermine, C. Kyriakou, A. Tanase, O. Tournilhac, W. Jurczak, I.E. Karsten, S.N. Quoc, Y. Serroukh, F. Stella, G. Wulf, A. Sureda, E. Papadavid, P.L. Ortiz-Romero, A. Ruggeri, I. Sanchez-Ortega, J.J. Scarisbrick, I. Yakoub-Agha, F. Onida, N. Schmitz
Pneumonia definition in allogeneic hematopoietic cell transplant recipients: Update and challenges in 2024. Recommendations from the EBMT Infectious Diseases Working Party and Practice Harmonization and Guidelines committee
2025 D. Neofytos, P.E. Verweij, D. Averbuch, M. Mikulska, J. Styczynski, J.L. Piñana, S. Cesaro, I. Sanchez-Ortega, R. Greco, F. Onida, I. Yakoub-Agha, P. Ljungman, R. De La Camara, A. Bergeron
Non-ICANS neurological complications after CAR T-cell therapies: recommendations from the EBMT Practice Harmonisation and Guidelines Committee
2025 C.E. Graham, R. Velasco, A. Alarcon Tomas, O.P. Stewart, G. Dachy, F. Del Bufalo, M. Doglio, J. Henter, G. Ortí, Z. Peric, C. Roddie, N.W.C.J. Van De Donk, M.J. Frigault, A. Ruggeri, F. Onida, I. Sánchez-Ortega, I. Yakoub-Agha, O. Penack
Role of allo-HCT in “nonclassical” MPNs and MDS/MPNs: recommendations from the PH&G Committee and the CMWP of the EBMT
2025 N. Polverelli, J.C. Hernández-Boluda, F. Onida, C. Gurnari, K. Raj, T. Czerw, M. Kenyon, M. Robin, K. Sockel, A. Ruggeri, I. Sánchez-Ortega, D.A. Arber, L. Arcaini, F.B. Duarte, G. Battipaglia, Y. Chalandon, F. Ciceri, N.C.P. Cross, J. Drozd-Sokolowska, V. Funke, N. Gagelmann, N. Gangat, J. Gotlib, P. Guglielmelli, C. Harrison, G. Hobbs, T. Jain, J.D. Khoury, J.J. Kiladjian, N. Kröger, L. Malcovati, M. Martino, R. Mesa, A. Orazi, E. Padron, F. Palandri, F. Passamonti, M.M. Patnaik, N. Pemmaraju, D.H. Radia, A. Reiter, D. Russo, C. Scheid, A. Tefferi, A.M. Vannucchi, D.H. Wiseman, I. Yakoub-Agha, D.P. Mclornan
Diagnostic accuracy of liver stiffness measurement for the diagnosis of veno-occlusive disease/sinusoidal obstruction syndrome after hematopoietic stem cell transplantation (HSCT), the ELASTOVOD STUDY: an investigator-initiated, prospective, multicentre diagnostic clinical trial
2025 F. Ravaioli, A. Colecchia, J. Peccatori, D. Pagliara, A. Grassi, F. Barbato, R. Masetti, B. Sarina, S. Sica, S. Cesaro, C. Nozzoli, G.M. Assanto, L. Prezioso, S. Santarone, F. Saglio, E. Vanni, A. Olivieri, M. Delia, E. Benedetti, F. Zallio, F. Pane, C. Skert, M. Menconi, F. Benedetti, F. De Felice, L. Colecchia, T. Belotti, L.V. Alemanni, M. Ursi, G. Marasco, M. Roberto, A. Vestito, E. Dajti, M. Garcovich, S. Bramanti, D. Taurino, F. Quagliarella, F. Ciceri, A. Prete, A. Pession, D. Festi, N. Null, M. Arpinati, E. Maffini, S. Falcione, R.M. Zagari, Z. Daniele, L. Lazzari, A. Rambaldi, L. Riccardi, V.D. Ruscio, E. Boccieri, M. Falcomer, V. Chiara, V. Vitale, C. Garonzi, F. Vizzutti, U. Arena, A.D. Santis, A. Rinaldi, A. Olivani, D. Vaddinelli, E.D. Lembo, M. Spadea, V. Apolito, D. Chiara, A. Busca, G. Mancini, G. Argalia, P. Carluccio, F. Passerini, A.D. Gangi, P. Rivela, R. Carbone, G. Battipaglia, F. Carobolante, I. Franceschet, F. Patriarca, M. Malagola, R. Varaldo, F. Onida, P. Vincenzo, F. Bonifazi, F. Bonifazi
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee
2024 F. Onida, N. Gagelmann, Y. Chalandon, G. Kobbe, M. Robin, A. Symeonidis, T.M. de Witte, R.A. Itzykson, M. Jentzsch, U. Platzbecker, V. Santini, G.F. Sanz, C. Scheid, E. Solary, P. Valent, R. Greco, I. Sánchez-Ortega, I. Yakoub-Agha, L. Pleyer
Harnessing the prognostic potential of PHF6 mutations in chronic myelomonocytic leukemia
2024 F. Onida
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms?
2024 C. Scheid, D. Eikema, M. Van Gelder, U. Salmenniemi, J. Maertens, J. Passweg, D. Blaise, J.L. Byrne, N. Kröger, K. Sockel, P. Chevallier, J.H. Bourhis, J.J. Cornelissen, H. Sengeloev, J. Finke, J.A. Snowden, T. Gedde-Dahl, J. Cornillon, U. Schanz, A. Patel, L. Koster, L.C. De Wreede, P. Hayden, K. Raj, J. Drozd-Sokolowska, C. Gurnari, F. Onida, D.P. Mclornan, M. Robin, I. Yakoub-Agha
Unrelated donor transplantation with posttransplant cyclophosphamide vs ATG for myelodysplastic neoplasms
2024 Y. Chalandon, D. Eikema, I. Moiseev, F. Ciceri, L. Koster, J. Vydra, J. Passweg, M. Rovira, T. Ozcelik, T. Gedde-Dahl, N. Kröger, V. Potter, I. Yakoub-Agha, A. Rambaldi, M. Itälä-Remes, A. Tanase, F. Onida, C. Gurnari, C. Scheid, J. Drozd-Sokolowska, K. Raj, D.P. Mclornan, M. Robin
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trial
2024 D. Russo, N. Polverelli, S. Bernardi, S. Santarone, M. Farina, E. Borlenghi, F. Onida, L. Castagna, S. Bramanti, A.M. Carella, R. Sorasio, M. Martino, C. Alati, A. Olivieri, G. Beltrami, A. Curti, C. Vetro, S. Leotta, V. Mancini, E. Terruzzi, M. Bernardi, P. Galieni, P. Musto, R. Cerretti, L. Giaccone, C. Skert, V. Radici, M. Vezzoli, S. Calza, A. Leoni, L. Garuffo, C. Bonvicini, S. Pellizzeri, M. Malagola, F. Ciceri